Exact Mass: 619.1996734
Exact Mass Matches: 619.1996734
Found 70 metabolites which its exact mass value is equals to given mass value 619.1996734
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
(1R,5S)-N-Cyclopropyl-7-(4-(2-(2,6-dichloro-4-methylphenoxy)ethoxy)phenyl)-N-(2,3-dimethylbenzyl)-3,9-diazabicyclo[3.3.1]non-6-ene-6-carboxamide
N-formylasimilobine 2-O-beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranoside|tinoscorside A
C30H37NO13 (619.2264792000001)
Asp His Trp Tyr
C30H33N7O8 (619.2390498000001)
Asp His Tyr Trp
C30H33N7O8 (619.2390498000001)
Asp Asn Trp Trp
C30H33N7O8 (619.2390498000001)
Asp Trp His Tyr
C30H33N7O8 (619.2390498000001)
Asp Trp Asn Trp
C30H33N7O8 (619.2390498000001)
Asp Trp Trp Asn
C30H33N7O8 (619.2390498000001)
Asp Trp Tyr His
C30H33N7O8 (619.2390498000001)
Asp Tyr His Trp
C30H33N7O8 (619.2390498000001)
Asp Tyr Trp His
C30H33N7O8 (619.2390498000001)
His Asp Trp Tyr
C30H33N7O8 (619.2390498000001)
His Asp Tyr Trp
C30H33N7O8 (619.2390498000001)
His Trp Asp Tyr
C30H33N7O8 (619.2390498000001)
His Trp Tyr Asp
C30H33N7O8 (619.2390498000001)
His Tyr Asp Trp
C30H33N7O8 (619.2390498000001)
His Tyr Trp Asp
C30H33N7O8 (619.2390498000001)
Asn Asp Trp Trp
C30H33N7O8 (619.2390498000001)
Asn Trp Asp Trp
C30H33N7O8 (619.2390498000001)
Asn Trp Trp Asp
C30H33N7O8 (619.2390498000001)
Trp Asp His Tyr
C30H33N7O8 (619.2390498000001)
Trp Asp Asn Trp
C30H33N7O8 (619.2390498000001)
Trp Asp Trp Asn
C30H33N7O8 (619.2390498000001)
Trp Asp Tyr His
C30H33N7O8 (619.2390498000001)
Trp His Asp Tyr
C30H33N7O8 (619.2390498000001)
Trp His Tyr Asp
C30H33N7O8 (619.2390498000001)
Trp Asn Asp Trp
C30H33N7O8 (619.2390498000001)
Trp Asn Trp Asp
C30H33N7O8 (619.2390498000001)
Trp Trp Asp Asn
C30H33N7O8 (619.2390498000001)
Trp Trp Asn Asp
C30H33N7O8 (619.2390498000001)
Trp Tyr Asp His
C30H33N7O8 (619.2390498000001)
Trp Tyr His Asp
C30H33N7O8 (619.2390498000001)
Tyr Asp His Trp
C30H33N7O8 (619.2390498000001)
Tyr Asp Trp His
C30H33N7O8 (619.2390498000001)
Tyr His Asp Trp
C30H33N7O8 (619.2390498000001)
Tyr His Trp Asp
C30H33N7O8 (619.2390498000001)
Tyr Trp Asp His
C30H33N7O8 (619.2390498000001)
Tyr Trp His Asp
C30H33N7O8 (619.2390498000001)
5-Carboxyrhodamine 6G, succinimidyl ester (5-CR 6G, SE)
Glesatinib
C31H27F2N5O3S2 (619.1523296000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
(4-{2-Acetylamino-2-[1-(3-carbamoyl-4-cyclohexylmethoxy-phenyl)-ethylcarbamoyl}-ethyl}-2-phosphono-phenoxy)-acetic acid
Cobalt,7,12,17-tetramethyl-8,13-divinyl-2,18-porphinedipropionato(2-))-
N-[(2R,3S)-2-[[(4-chlorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide
C27H33ClF3N3O6S (619.1730584000002)
N-phenylcarbamic acid [(2R,3R,4S,5R,6S)-5-[anilino(oxo)methoxy]-2-(hydroxymethyl)-6-methoxy-3-[oxo-[4-(trifluoromethyl)anilino]methoxy]-4-oxanyl] ester
N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]benzenesulfonamide
C30H35Cl2N3O5S (619.1674360000001)
N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]benzenesulfonamide
C30H35Cl2N3O5S (619.1674360000001)
N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]benzenesulfonamide
C30H35Cl2N3O5S (619.1674360000001)
N-[(2S,3R)-2-[[(4-chlorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide
C27H33ClF3N3O6S (619.1730584000002)
N-[(2R,3R)-2-[[(4-chlorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide
C27H33ClF3N3O6S (619.1730584000002)
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-thiophenesulfonamide
N-[(2S,3S)-2-[[(4-chlorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide
C27H33ClF3N3O6S (619.1730584000002)
N-[(2R,3R)-2-[[(4-chlorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide
C27H33ClF3N3O6S (619.1730584000002)
N-[(2S,3S)-2-[[(4-chlorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide
C27H33ClF3N3O6S (619.1730584000002)
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-methylbenzenesulfonamide
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1-{2,6-dihydroxy-4-[(E)-2-(4-hydroxyphenyl)ethenyl]phenyl}-1-hydroxy-3-methylbutan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C29H37N3O10S (619.2199542000001)
{[2,3,4-tri-O-acetyl-6-O-(2,3,5-tri-O-acetyl-alpha-D-arabinofuranosyl)-alpha-D-mannopyranosyl]thio}acetonitrile
C25H33NO15S (619.1570828000001)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-{3,5-dihydroxy-4-[(1E)-3-methylbut-1-en-1-yl]phenyl}-2-hydroxy-1-(4-hydroxyphenyl)ethyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C29H37N3O10S (619.2199542000001)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1-{3,5-dihydroxy-4-[(1E)-3-methylbut-1-en-1-yl]phenyl}-2-hydroxy-2-(4-hydroxyphenyl)ethyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C29H37N3O10S (619.2199542000001)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1-{2,6-dihydroxy-4-[(E)-2-(4-hydroxyphenyl)ethenyl]phenyl}-2-hydroxy-3-methylbutyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C29H37N3O10S (619.2199542000001)
Vemtoberant
C29H37N3O8S2 (619.2021962000001)
Vemtoberant is an β3 Adrenergic Receptor antagonist. Vemtoberant can be used for research of β3 adrenergic receptor-mediated disorder, such as, heart failure[1][2].
15-{[4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-16-methoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaene-10-carbaldehyde
C30H37NO13 (619.2264792000001)